文献速递腹部技术与安全US

超声定量肝脂肪变性:衰减成像系数在活检证实队列中的前景

Quantification of hepatic steatosis with ultrasound: promising role of attenuation imaging coefficient in a biopsy-proven cohort.
PubMed 文献 · Eur Radiol · 2019-12-10

该前瞻性研究纳入101例同日行肝活检和超声衰减成像系数(AC)测量的患者,评估AC对肝脂肪变性的诊断和定量价值。AC与病理脂肪变性百分比呈正相关(r=0.58),诊断任何级别脂肪变性的AUROC为0.805,诊断S2-S3的AUROC为0.892。AC是一种有前景的无创定量肝脂肪变性技术。

要点

  • AC与病理脂肪变性程度正相关(r=0.58),可用于无创定量脂肪变性。
  • AC>0.69 dB/cm/MHz诊断S1-S3的敏感度76%、特异度86%。
  • AC>0.72 dB/cm/MHz诊断S2-S3的敏感度96%、特异度74%。

诊断标准与关键数值

  • AC诊断任何级别脂肪变性(S1-S3)的AUROC为0.805,阈值AC>0.69 dB/cm/MHz时敏感度76%、特异度86%。
  • AC诊断S2-S3的AUROC为0.892,阈值AC>0.72 dB/cm/MHz时敏感度96%、特异度74%。
  • 脂肪变性任何级别患者AC高于无脂肪变性患者(0.77±0.13 vs. 0.63±0.09 dB/cm/MHz,p<0.01)。
  • S2-S3患者AC高于S0-1患者(0.85±0.11 vs. 0.67±0.11 dB/cm/MHz,p<0.01)。

临床应用与阅片要点

  • AC测量技术成功率很高,可作为肝脂肪变性的无创定量工具。
  • 晚期纤维化(F3-F4)的存在不影响AC的计算。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To prospectively assess the role of the US attenuation imaging coefficient (AC) for the diagnosis and quantification of hepatic steatosis.

METHODS: One hundred and one patients underwent liver biopsy and US-AC measurement on the same day. Liver steatosis was graded according to biopsy as absent (S0 < 5%), mild (S1 5-33%), moderate (S2 33-66%), or severe (S3 > 66%); liver fibrosis was graded from F0 to F4. The correlation between AC and steatosis on pathology (%) was calculated using the Pearson correlation coefficient. The Student t or Mann-Whitney U test was used to compare continuous variables and ROC curve analysis was used to assess diagnostic performance of AC in diagnosing steatosis.

RESULTS: Overall, 43 (42%), 35 (35%), 12 (12%), and 11 (11%) patients were classified as S0, S1, S2, and S3, respectively. The AC was positively correlated with steatosis as a continuous variable (%) on pathology (r = 0.58, p < 0.01). Patients with steatosis of any grade had a higher AC than those without steatosis (mean 0.77 ± 0.13 vs. 0.63 ± 0.09 dB/cm/MHz, respectively; p < 0.01, AUROC = 0.805). Patients with S2-S3 had a higher AC than patients with S0-1 (0.85 ± 0.11 vs. 0.67 ± 0.11 dB/cm/MHz, respectively; p < 0.01, AUROC = 0.892). AC > 0.69 dB/cm/MHz had a sensitivity and specificity of 76% and 86%, respectively, for diagnosing any grade of steatosis (S1-S3), and AC > 0.72 dB/cm/MHz had a sensitivity and specificity of 96% and 74%, respectively, for diagnosing S2-S3. The presence of advanced fibrosis (F3-F4) did not affect the calculated AC.

CONCLUSIONS: The attenuation imaging coefficient is a promising quantitative technique for the non-invasive diagnosis and quantification of hepatic steatosis.

KEY POINTS: • Measurement of the attenuation coefficient is achieved with a very high rate of technical success. • We found a significant positive correlation between the attenuation coefficient and the grade of steatosis on pathology. • The attenuation imaging coefficient is a promising quantitative technique for the noninvasive diagnosis and quantification of hepatic steatosis.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Dioguardi Burgio M, Ronot M, Reizine E, et al. Quantification of hepatic steatosis with ultrasound: promising role of attenuation imaging coefficient in a biopsy-proven cohort. Eur Radiol. 2019. PMID: 31822978. doi:10.1007/s00330-019-06480-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。